Results 11 to 20 of about 615,884 (310)
Inhibitor-sensitive FGFR1 amplification in human non-small cell lung cancer. [PDF]
PLoS ONE, 2011 Squamous cell lung carcinomas account for approximately 25% of new lung carcinoma cases and 40,000 deaths per year in the United States. Although there are multiple genomically targeted therapies for lung adenocarcinoma, none has yet been reported in ...
Amit Dutt +11 more
doaj +14 more sources
Case Report: Pathological diagnosis of left upper lobe nodules: two cases of composite small cell lung cancer and literature review [PDF]
Frontiers in OncologyCombined Small Cell Lung Cancer (C-SCLC) is defined by the World Health Organization (WHO) as a combination of Small Cell Lung Cancer (SCLC) and other components, which may include any type of Non-Small Cell Lung Cancer (NSCLC).
Jishen Zhang +3 more
doaj +2 more sources
Cetuximab and biomarkers in non-small-cell lung carcinoma
Biologics: Targets & Therapy, 2012 Nitin Patil, Mohammed Abba, Heike AllgayerDepartment of Experimental Surgery, Medical Faculty Mannheim, University of Heidelberg and Molecular Oncology of Solid Tumors Unit, German Cancer Research Center (DKFZ), Heidelberg, GermanyAbstract: Cancer ...
Patil N, Abba M, Allgayer H
doaj +4 more sources
Targeted therapy of non-small-cell lung carcinoma [PDF]
Therapeutic Advances in Respiratory Disease, 2012 The rapid expansion of novel technologies in cancer research over the past several years has led to a dramatically improved understanding of the molecular biology of lung cancer. As a consequence, novel targeted therapies are rapidly being developed.
Divya Tiwari +2 more
doaj +3 more sources
Journal of Medical Sciences and Health, 2023 Background : Lung cancer is the leading cause of cancer-related mortality over worldwide. Although the pathological diagnosis of lung carcinoma is limited as only small specimen available for diagnosis, the availability of targeted therapies has
Mayank Agrawal +4 more
doaj +1 more source
the Immunohistochemical Study of Stathmin-1 as A Prognostic factor In Non-small cell lung carcinoma
مجلة كلية الطب, 2023 Background Stathmin1 (also known as metablastin) is a major microtubule-depolymerizing protein that involved in cell cycle progression and cell motility.
Nadhema Bahaa Hussein Wetwet +3 more
doaj +1 more source
Lung Cancer: A Literature Review
Jurnal Respirasi, 2023 Lung cancer is a cancer whose onset starts in the lungs where there is an abnormal cell growth that is very fast and uncontrolled. The abnormal cell growth is triggered by deoxyribonucleic acid (DNA) damage, including deletions in the DNA section ...
Yan Efrata Sembiring +8 more
doaj +1 more source
Thoracic Cancer, 2021 Immune checkpoint inhibitors with chemotherapy have been shown to exhibit remarkable efficacy for advanced non‐small‐cell lung carcinoma and are under investigation as an induction therapy.
Shunichi Saito +6 more
doaj +1 more source
Lung: Non-small cell carcinoma [PDF]
Atlas of Genetics and Cytogenetics in Oncology and Haematology, 2011 Non-small cell carcinomas are divided into three main categories according to the predominant morphology of the tumour cells as determined by light microscopy. Although it is possible to distinguish different histological sub-groups in this way, or by using gene expression profiling, treatment is currently decided on the basis of tumour staging, age ...
J Heighway, DC Betticher
openaire +1 more source
The Journal of Association of Chest Physicians, 2023 Spindle cell carcinoma is one of the histological variants of pulmonary sarcomatoid carcinoma. It is a rare, poorly differentiated, highly malignant, and rapidly growing non-small cell carcinoma of the lung.
Pratap Upadhya +3 more
doaj +1 more source